Cargando…

Proton Beam Therapy Alone for Intermediate- or High-Risk Prostate Cancer: An Institutional Prospective Cohort Study

The role of proton beam therapy (PBT) as monotherapy for localized prostate cancer (PCa) remains unclear. The purpose of this study was to evaluate the efficacy and adverse events of PBT alone for these patients. Between January 2011 and July 2014, 218 patients with intermediate- and high-risk PCa w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arimura, Takeshi, Yoshiura, Takashi, Matsukawa, Kyoko, Kondo, Naoaki, Kitano, Ikumi, Ogino, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923371/ https://www.ncbi.nlm.nih.gov/pubmed/29642619 http://dx.doi.org/10.3390/cancers10040116

Ejemplares similares

Health-related quality of life in Japanese patients with prostate cancer following proton beam therapy: an institutional cohort study
por: Matsukawa, Kyoko, et al.
Publicado: (2020)

Clinical Outcomes of Proton Beam Therapy for Ground-Glass Opacity-Type Lung Cancer
por: Nagata, Ichiro, et al.
Publicado: (2020)

Pacemaker malfunction associated with proton beam therapy: a report of two cases and review of literature—does field-to-generator distance matter?
por: Ueyama, Tomoko, et al.
Publicado: (2016)

Proton beam therapy for extrahepatic biliary tract cancer: Analysis with prospective multi-institutional patients’ registration database, Proton-Net
por: Yamazaki, Hideya, et al.
Publicado: (2023)

Multi-Institutional Retrospective Analysis of the Outcomes of Proton Beam Therapy for Patients With 1 to 3 Pulmonary Oligometastases From Various Primary Cancers
por: Aibe, Norihiro, et al.
Publicado: (2021)

Particle Beam Therapy for Intrahepatic and Extrahepatic Biliary Duct Carcinoma: A Multi-Institutional Retrospective Data Analysis
por: Yamazaki, Hideya, et al.
Publicado: (2022)

Histogram analysis with automated extraction of brain-tissue region from whole-brain CT images
por: Kondo, Masatoshi, et al.
Publicado: (2015)

Optimal Androgen Deprivation Therapy Combined with Proton Beam Therapy for Prostate Cancer: Results from a Multi-Institutional Study of the Japanese Radiation Oncology Study Group
por: Murakami, Motohiro, et al.
Publicado: (2020)

Amide Proton Transfer Imaging of Cavernous Malformation in the Cavernous Sinus
por: Bohara, Manisha, et al.
Publicado: (2018)

I-131 false-positive uptake in a thymic cyst with expression of the sodium-iodide symporter: A case report
por: Yano, Erina, et al.
Publicado: (2022)

Long‐term outcomes of proton therapy for prostate cancer in Japan: a multi‐institutional survey of the Japanese Radiation Oncology Study Group
por: Iwata, Hiromitsu, et al.
Publicado: (2018)

Prostate-specific antigen kinetics in hypofractionated radiation therapy alone for intermediate- and high-risk localized prostate cancer
por: Lee, Tae Hoon, et al.
Publicado: (2023)

Proton beam therapy for gliomas: a multicenter prospective registry study from all proton beam facilities in Japan
por: Mori, Takashi, et al.
Publicado: (2023)

Hypofractionated proton beam radiotherapy in patients with unresectable liver tumors: multi-institutional prospective results from the Proton Collaborative Group
por: Parzen, Jacob S., et al.
Publicado: (2020)

Analysis of Gastrointestinal Toxicity in Patients Receiving Proton Beam Therapy for Prostate Cancer: A Single-Institution Experience
por: Lee, Howard J., et al.
Publicado: (2018)

Intermediate-energy polarimeter for the measurement of the deuteron and proton beam polarization at the JINR synchrophasotron
por: Azhgirey, L S, et al.
Publicado: (2002)

Cryotherapy for Primary Treatment of Prostate Cancer: Intermediate Term Results of a Prospective Study from a Single Institution
por: Rodríguez, S. Alvarez, et al.
Publicado: (2014)

Clinical outcomes of low-dose-rate brachytherapy based radiotherapy for intermediate risk prostate cancer
por: Okamoto, Keisei, et al.
Publicado: (2020)

Comparison of multi‐institutional Varian ProBeam pencil beam scanning proton beam commissioning data
por: Langner, Ulrich W., et al.
Publicado: (2017)

Relative biological effectiveness of therapeutic proton beams for HSG cells at Japanese proton therapy facilities
por: Aoki-Nakano, Mizuho, et al.
Publicado: (2014)

Increasing rectum–prostate distance using a hydrogel spacer to reduce radiation exposure during proton beam therapy for prostate cancer
por: Narukawa, Tsukasa, et al.
Publicado: (2023)

Correlation between amide proton transfer-related signal intensity and diffusion and perfusion magnetic resonance imaging parameters in high-grade glioma
por: Nakajo, Masanori, et al.
Publicado: (2021)

Light flash and odor during proton beam therapy for pediatric patients: a prospective observational study
por: Mizumoto, Masashi, et al.
Publicado: (2022)

Upgrading prostate cancer following proton beam therapy
por: Logan, Jennifer K., et al.
Publicado: (2015)

Capacity of proton beams in preserving normal liver tissue during proton beam therapy for hepatocellular carcinoma
por: Tsai, Yu-Lun, et al.
Publicado: (2020)

Analysis of the cost‐effectiveness of proton beam therapy for unresectable pancreatic cancer in Japan
por: Hiroshima, Yuichi, et al.
Publicado: (2023)

Symposium on Science with Intense Proton Beam
por: Kondó, Michiya, et al.
Publicado: (1986)

A Multi-Institutional Experience of Proton Beam Therapy for Sinonasal Tumors
por: Yu, Nathan Y., et al.
Publicado: (2019)

Chronoradiation Therapy for Prostate Cancer: Morning Proton Beam Therapy Ameliorates Worsening Lower Urinary Tract Symptoms
por: Negoro, Hiromitsu, et al.
Publicado: (2020)

Treatment interruptions affect biochemical failure rates in prostate cancer patients treated with proton beam therapy: Report from the multi-institutional proton collaborative group registry
por: Han, James E., et al.
Publicado: (2020)

Internal Beam Measurements and the Deflection Protons from the Gustaf Werner Institute Cyclotron
por: Taylor, A E
Publicado: (1953)

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios alone or combined with prostate-specific antigen for the diagnosis of prostate cancer and clinically significant prostate cancer
por: Nepal, Sat Prasad, et al.
Publicado: (2023)

Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: Results of two prospective trials
por: Henderson, Randal H., et al.
Publicado: (2013)

Investigation of whether in-room CT-based adaptive intracavitary brachytherapy for uterine cervical cancer is robust against interfractional location variations of organs and/or applicators
por: Oku, Yoshifumi, et al.
Publicado: (2016)

A comparative study of high-dose-rate brachytherapy boost combined with external beam radiation therapy versus external beam radiation therapy alone for high-risk prostate cancer
por: Oshikane, Tomoya, et al.
Publicado: (2021)

Simulation study using the spots deletion technique in spot scanning proton beam therapy for prostate cancers
por: Fukumitsu, Nobuyoshi, et al.
Publicado: (2022)

Proton beam therapy for muscle-invasive bladder cancer: A systematic review and analysis with Proton-Net, a multicenter prospective patient registry database
por: Araya, Masayuki, et al.
Publicado: (2023)

Antiproton-proton colliders and intermediate bosons
por: Cline, D, et al.
Publicado: (1980)

Fast fluoride ion conduction of NH(4)(Mg(1-x)Li(x))F(3-x) and (NH(4))(2)(Mg(1-x)Li(x))F(4-x) assisted by molecular cations
por: Motohashi, Kota, et al.
Publicado: (2022)

Proton beam therapy and localised prostate cancer: current status and controversies
por: Efstathiou, J A, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_m0rctb4rjscdocco885fasl19e